Treatment of septic shock with anti-tnf antibodies

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) C07K 16/24 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2198316

A method of treating a mammal in an established state of septic shock, the method comprising administering a clinically effective dose of anti-TNF monoclonal antibodies to the mammal, said antibodies being administered under conditions sufficient to alleviate the state of shock and reduce the likelihood of mortality.

Méthode pour traiter un mammifère dans un état de choc septique établi, la méthode comprenant l'administration au mammifère d'une dose cliniquement efficace d'anticorps monoclonaux anti-TNF, lesdits anticorps étant administrés dans des conditions suffisantes pour atténuer l'état de choc et réduire la probabilité de mort.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of septic shock with anti-tnf antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of septic shock with anti-tnf antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of septic shock with anti-tnf antibodies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1655891

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.